Tiragolumab and atezolizumab: ORR in NSCLC Presented ByDr Delvys Rodriguez-Abreu, NYU Perlmutter Cancer Center, USA TrialPhase 2, CITYSCAPE ConferenceASCO 2020 8 September, 2020 13:15